These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38714518)
1. Correlation between urine cytology results on the day after overnight continuous saline irrigation following transurethral resection of bladder tumor and bladder tumor recurrence. Kim DH; Choi MS; Choi JH; Lee C; Jeh SU; Kam SC; Hwa JS; Hyun JS; Choi SM Investig Clin Urol; 2024 May; 65(3):279-285. PubMed ID: 38714518 [TBL] [Abstract][Full Text] [Related]
2. Continuous saline bladder irrigation after blue light transurethral resection of bladder tumor increases recurrence-free survival in low- to intermediate-risk non-muscle invasive bladder cancer. Gondran-Tellier B; Abdallah R; Sichez PC; Akiki A; Toledano H; Gaillet S; Delaporte V; Karsenty G; Bastide C; Daniel L; Garcia S; Rossi D; Lechevallier E; Boissier R; Baboudjian M Prog Urol; 2021 May; 31(6):316-323. PubMed ID: 33663939 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: A prospective study. Elsawy AA; Harraz AM; Ghobrial FK; Abdullatef M; Ali-El-Dein B Urol Oncol; 2020 Dec; 38(12):935.e1-935.e8. PubMed ID: 32654947 [TBL] [Abstract][Full Text] [Related]
4. [A real-world study of the clinical application of the Paris system for reporting urinary cytology in cancer hospital]. Zhao H; Zhang ZH; Guo HQ; Wei N; Ma HY; Zhao LL; Sun Y; Wang C; Chang XX; Bi XG; Xing NZ Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):703-709. PubMed ID: 39034806 [No Abstract] [Full Text] [Related]
5. Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer. Fujita N; Hatakeyama S; Okita K; Momota M; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C Urol Oncol; 2021 Jan; 39(1):75.e9-75.e16. PubMed ID: 32665123 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of urine cytology as a routine work-up in the detection of recurrence in patients with prior non-muscle-invasive bladder cancer: practicality and cost-effectiveness. Ok BG; Ji YS; Ko YH; Song PH Korean J Urol; 2014 Oct; 55(10):650-5. PubMed ID: 25324947 [TBL] [Abstract][Full Text] [Related]
7. Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis. Matsushita Y; Miyake M; Nishimura N; Nishimoto K; Fukuhara H; Kobayashi K; Oyama M; Inoue K; Matsuyama H; Fujimoto K; Miyake H Int J Clin Oncol; 2024 Feb; 29(2):205-212. PubMed ID: 38112832 [TBL] [Abstract][Full Text] [Related]
8. The predictive value of positive and suspicious urine cytology: Are they different? Kuan KC; Segura SE; Ahlstedt J; Khader SN; Hakima L Diagn Cytopathol; 2020 Nov; 48(11):998-1002. PubMed ID: 32558388 [TBL] [Abstract][Full Text] [Related]
9. The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? Pierconti F; Martini M; Fiorentino V; Cenci T; Capodimonti S; Straccia P; Sacco E; Pugliese D; Cindolo L; Larocca LM; Bassi PF Urol Oncol; 2021 Feb; 39(2):131.e17-131.e21. PubMed ID: 32773233 [TBL] [Abstract][Full Text] [Related]
10. Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with intravesical Mitomycin-C. Lenis AT; Asanad K; Blaibel M; Donin NM; Chamie K BMC Urol; 2018 Oct; 18(1):93. PubMed ID: 30355350 [TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of tumor location in nonmuscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing Chinese multicenter and SEER registries. Liu L; Li K; Wang SG; Wang J; Yao Z; Xie Y; Ji Z; Chen Z; Hu H; Chen H; Hu J; Hou Y; Liu Z; Li Y; Ding Y; Kuang Y; Xun Y; Hu J; Zhang J; Li H; Chong T; Bi J; Wang Z; Wang Y; Zhang P; Wei Q; Chen Z; Li L; Huang J; Liu Z; Chen K; Int J Surg; 2024 Sep; 110(9):5641-5651. PubMed ID: 38788195 [TBL] [Abstract][Full Text] [Related]
12. The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer. Onishi T; Sekito S; Shibahara T; Uchida K; Sasaki T Scand J Urol; 2018; 52(5-6):385-388. PubMed ID: 30628540 [TBL] [Abstract][Full Text] [Related]
13. Thulium laser en bloc resection reduces recurrence rates in NMIBC patients with tumor diameters ≥3cm compared to transurethral resection: a non-randomized controlled study. Yao Z; Li Y; Ding Y; Hou Y; Hu J; Liu Z; Shi P; Hu H; Li F; Hu J; Song W; Song X; Chen K; Liu L; Liu Z BMC Cancer; 2024 Oct; 24(1):1239. PubMed ID: 39379837 [TBL] [Abstract][Full Text] [Related]
14. [The significance of urine cytology three consecutive days after transurethral resection as a predictor of superficial bladder cancer recurrence]. Yumura Y; Takase K; Kato Y; Hamano A; Mikata K; Ogo Y; Noguchi S; Satomi Y Hinyokika Kiyo; 2004 Mar; 50(3):171-6. PubMed ID: 15148768 [TBL] [Abstract][Full Text] [Related]
15. Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle-invasive bladder cancer. Onishi T; Sugino Y; Shibahara T; Masui S; Yabana T; Sasaki T BJU Int; 2017 Feb; 119(2):276-282. PubMed ID: 27444991 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Preoperative Urine Cytology in Low-grade Non-muscle-invasive Bladder Cancer. Kiyoshima K; Akitake M; Shiota M; Takeuchi A; Takahashi R; Inokuchi J; Tatsugami K; Yokomizo A; Eto M Anticancer Res; 2016 Feb; 36(2):799-802. PubMed ID: 26851042 [TBL] [Abstract][Full Text] [Related]
17. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens. McIntire PJ; Snow JT; Elsoukkary SS; Soong L; Sweeney J; Robinson BD; Siddiqui MT Cancer Cytopathol; 2019 Feb; 127(2):120-124. PubMed ID: 30395388 [TBL] [Abstract][Full Text] [Related]
18. Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival. Mastroianni R; Brassetti A; Krajewski W; Zdrojowy R; Salhi YA; Anceschi U; Bove AM; Carbone A; De Nunzio C; Fuschi A; Ferriero M; Nacchia A; Pastore AL; Tema G; Tuderti G; Gallucci M; Simone G Eur Urol Focus; 2021 Nov; 7(6):1324-1331. PubMed ID: 32900676 [TBL] [Abstract][Full Text] [Related]
19. [Practical application of the Paris system for reporting urinary cytology]. Chen L; Liu LT; Sun MJ; He SR; Liu DG Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):470-476. PubMed ID: 38678328 [No Abstract] [Full Text] [Related]
20. Utility of the Paris System in Urine Cytology for Improved Screening of High-Grade Urothelial Carcinoma in Bahrain. Mahmoud Daoud R; Ali AH; Salim Fredericks S; Daoud S; Gomaa HR; AlHashimi FS Cureus; 2024 Mar; 16(3):e57189. PubMed ID: 38681345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]